Free Trial
NASDAQ:OMCL

Omnicell (OMCL) Stock Price, News & Analysis

Omnicell logo
$29.77 -0.17 (-0.57%)
Closing price 07/10/2025 04:00 PM Eastern
Extended Trading
$29.60 -0.18 (-0.59%)
As of 07:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Omnicell Stock (NASDAQ:OMCL)

Key Stats

Today's Range
$29.61
$30.19
50-Day Range
$24.63
$31.68
52-Week Range
$22.66
$55.75
Volume
303,144 shs
Average Volume
561,461 shs
Market Capitalization
$1.39 billion
P/E Ratio
64.72
Dividend Yield
N/A
Price Target
$44.83
Consensus Rating
Moderate Buy

Company Overview

Omnicell Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

OMCL MarketRank™: 

Omnicell scored higher than 41% of companies evaluated by MarketBeat, and ranked 460th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Omnicell has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Omnicell has only been the subject of 4 research reports in the past 90 days.

  • Read more about Omnicell's stock forecast and price target.
  • Earnings Growth

    Earnings for Omnicell are expected to grow by 13.76% in the coming year, from $1.09 to $1.24 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Omnicell is 64.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Omnicell is 64.72, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.23.

  • Price to Book Value per Share Ratio

    Omnicell has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Omnicell's valuation and earnings.
  • Percentage of Shares Shorted

    5.39% of the float of Omnicell has been sold short.
  • Short Interest Ratio / Days to Cover

    Omnicell has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Omnicell has recently increased by 8.37%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Omnicell does not currently pay a dividend.

  • Dividend Growth

    Omnicell does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.39% of the float of Omnicell has been sold short.
  • Short Interest Ratio / Days to Cover

    Omnicell has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Omnicell has recently increased by 8.37%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Omnicell this week, compared to 6 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Omnicell insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.52% of the stock of Omnicell is held by insiders.

  • Percentage Held by Institutions

    97.70% of the stock of Omnicell is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Omnicell's insider trading history.
Receive OMCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omnicell and its competitors with MarketBeat's FREE daily newsletter.

OMCL Stock News Headlines

3 Cash-Heavy Stocks Facing Headwinds
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Omnicell CFO Nchacha Etta to Step Down
What Analysts Are Saying About Omnicell Stock
See More Headlines

OMCL Stock Analysis - Frequently Asked Questions

Omnicell's stock was trading at $44.52 at the beginning of 2025. Since then, OMCL stock has decreased by 33.1% and is now trading at $29.77.

Omnicell, Inc. (NASDAQ:OMCL) released its quarterly earnings results on Tuesday, May, 6th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.16 by $0.10. The business's revenue was up 9.5% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Omnicell: MarkeTouch Media LLC, ReCept Pharmacy, FDS Amplicare, 340B Link Business, InPharmics, Ateb Inc., Aesynt, and others.

Shares of OMCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Omnicell investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Broadcom (AVGO) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/06/2025
Today
7/11/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:OMCL
CIK
926326
Employees
3,670
Year Founded
1992

Price Target and Rating

High Price Target
$64.00
Low Price Target
$34.00
Potential Upside/Downside
+50.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.46
Trailing P/E Ratio
64.72
Forward P/E Ratio
27.31
P/E Growth
N/A
Net Income
$12.53 million
Net Margins
1.87%
Pretax Margin
2.98%
Return on Equity
4.60%
Return on Assets
2.56%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
1.38
Quick Ratio
1.23

Sales & Book Value

Annual Sales
$1.11 billion
Price / Sales
1.25
Cash Flow
$3.04 per share
Price / Cash Flow
9.78
Book Value
$26.84 per share
Price / Book
1.11

Miscellaneous

Outstanding Shares
46,840,000
Free Float
45,664,000
Market Cap
$1.39 billion
Optionable
Optionable
Beta
0.76

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:OMCL) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners